US 7815916
Cloning and expression of HTLV-III DNA
granted A61KA61K38/00
Quick answer
US patent 7815916 (Cloning and expression of HTLV-III DNA) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Health and Human Services
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 78
- CPC classes
- A61K, A61K38/00